Correlation Between Clearpoint Neuro and MaxCyte
Can any of the company-specific risk be diversified away by investing in both Clearpoint Neuro and MaxCyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clearpoint Neuro and MaxCyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clearpoint Neuro and MaxCyte, you can compare the effects of market volatilities on Clearpoint Neuro and MaxCyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clearpoint Neuro with a short position of MaxCyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clearpoint Neuro and MaxCyte.
Diversification Opportunities for Clearpoint Neuro and MaxCyte
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Clearpoint and MaxCyte is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Clearpoint Neuro and MaxCyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MaxCyte and Clearpoint Neuro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clearpoint Neuro are associated (or correlated) with MaxCyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MaxCyte has no effect on the direction of Clearpoint Neuro i.e., Clearpoint Neuro and MaxCyte go up and down completely randomly.
Pair Corralation between Clearpoint Neuro and MaxCyte
Given the investment horizon of 90 days Clearpoint Neuro is expected to generate 1.26 times more return on investment than MaxCyte. However, Clearpoint Neuro is 1.26 times more volatile than MaxCyte. It trades about 0.05 of its potential returns per unit of risk. MaxCyte is currently generating about -0.01 per unit of risk. If you would invest 721.00 in Clearpoint Neuro on September 2, 2024 and sell it today you would earn a total of 516.00 from holding Clearpoint Neuro or generate 71.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Clearpoint Neuro vs. MaxCyte
Performance |
| Timeline |
| Clearpoint Neuro |
| MaxCyte |
Clearpoint Neuro and MaxCyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Clearpoint Neuro and MaxCyte
The main advantage of trading using opposite Clearpoint Neuro and MaxCyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clearpoint Neuro position performs unexpectedly, MaxCyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MaxCyte will offset losses from the drop in MaxCyte's long position.| Clearpoint Neuro vs. Avita Medical | Clearpoint Neuro vs. Sight Sciences | Clearpoint Neuro vs. Treace Medical Concepts | Clearpoint Neuro vs. Neuropace |
| MaxCyte vs. Sight Sciences | MaxCyte vs. CVRx Inc | MaxCyte vs. Neuropace | MaxCyte vs. Rapid Micro Biosystems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |